Page last updated: 2024-11-05

tolbutamide and Acquired Autoimmune Hemolytic Anemia

tolbutamide has been researched along with Acquired Autoimmune Hemolytic Anemia in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lübbers, P1

Other Studies

1 other study available for tolbutamide and Acquired Autoimmune Hemolytic Anemia

ArticleYear
[Autoimmune hemolytic anemia following alpha-methyldopa therapy].
    Deutsche medizinische Wochenschrift (1946), 1968, Dec-20, Volume: 93, Issue:51

    Topics: Adrenal Cortex Hormones; Aged; Anemia, Hemolytic, Autoimmune; Coombs Test; Diabetes Mellitus; Female

1968